Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 3/20 | 0.47 |
| ▸ | CTSS | P25774 | 3/20 | 0.47 |
| ▸ | CTSK | P43235 | 3/20 | 0.47 |
| ▸ | CTSH | P09668 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 12/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.43 |
| ▸ | NPY1R | P25929 | 8/20 | 0.43 |
| ▸ | NPY2R | P49146 | 6/20 | 0.43 |
| ▸ | PRKACB | P22694 | 1/20 | 0.42 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.41 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31437155 | 0.94 | SLC15A2 (0.44) | CTSLCTSSCTSKCTSHNPY4R | |
| SCHEMBL29614491 | 0.91 | CTSL (0.46) | CTSLCTSSCTSKCTSHIL23R | |
| SCHEMBL29614488 | 0.91 | CTSL (0.46) | CTSLCTSSCTSKCTSHIL23R | |
| SCHEMBL31467761 | 0.91 | SLC15A2 (0.46) | NPY4RNPY5RNPY1RNPY2RPRKACB | |
| SCHEMBL30595069 | 0.88 | SIRT6 (0.41) | NPBWR1IL23R | |
| SCHEMBL29562123 | 0.86 | SLC15A2 (0.43) | NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL31315020 | 0.86 | SLC15A2 (0.43) | NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL29614462 | 0.86 | TFPI (0.46) | CTSLCTSSCTSKCTSHIL23R | |
| SCHEMBL31467765 | 0.85 | NPY4R (0.47) | NPY4RNPY5RNPY1RNPY2RPRKACB | |
| SCHEMBL31437199 | 0.85 | CTSL (0.54) | CTSLCTSSCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | claimed |
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | claimed |
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |